Dave Vreeland
Founder and Senior Managing Partner @ Caduceus Capital Partners
Nashville, United States
Dave Vreeland is a Series A investor at Caduceus Capital Partners in Nashville focused on Health Care and Medical. Dave Vreeland is the Managing Director at Jumpstart Capital and the Member of the Board of Directors at Simplify ASC.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 88%
Last updated:
For AI agents: llms.txt
Industries Dave Vreeland invests in
Stages Dave Vreeland invests in
Countries Dave Vreeland invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 6 (75%)
- Medical 3 (38%)
- Personal Health 3 (38%)
- Software 2 (25%)
- Medical Device 2 (25%)
Stage
- Series A 5 (63%)
- Venture - Series Unknown 2 (25%)
- Seed 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Tombot specializes in creating robotic animals and digital health solutions. The company targets a market of over 200 million individuals living with dementia or pre-dementia mild cognitive impairment. Research has demonstrated that robotic animals can effectively alleviate behavioral and psychological symptoms associated with dementia, includingloneliness, anxiety, depression, hallucinations, and violent anger, while also reducing the dependence on harmful psychotropic medications. Tombot’s mission is encapsulated in its tagline, "A dog for people who can’t have dogs. | $6.1M / Series A / Jun 12, 2025 | ||
| Reperio is the first and only company in the world to bring lab quality access for preventative screenings into the home. Their patented technology using our current screening kit gives users real-time, instant access to their Blood Pressure, Resting Heart Rate, BMI, Relative Fat Mass, Total Cholesterol, HDL, LDL, Triglycerides and Glucose. ThroughReperioCare, they are also a licensed medical practice that follows up these screenings with an on-demand, AI-assisted virtual visit with a licensed medical professional. | $14M / Venture - Series Unknown / Apr 19, 2025 | ||
| VoiceCare AI operates as a Healthcare Administration General Intelligence (HAGI) company. | $4.5M / Seed / Feb 14, 2025 | ||
| UptimeHealth, headquartered in Boston, MA, is a software startup that simplifies medical device service events, purchases, and compliance practices through automation and predictive analytics.The company focuses on providing administrators and operators with simple-to-use software to manage compliance tasks, gain access to actionable data toincrease operational efficiencies, and tap into the largest network of qualified biomed technicians to support their medical devices. | $4.5M / Series A / Jan 26, 2023 | ||
| ScriptDrop’s technology platform enables connectivity across the healthcare ecosystem connecting patients, pharmacists, providers, and pharmaceutical manufacturers. The platform provides a seamless experience for patients, offering them prescription delivery in all 50 states and allowing for important additional services to be provided for betteradherence.The company was founded in 2016 and is headquartered in Columbus, Ohio. | $1.6M / Venture - Series Unknown / Feb 21, 2022 | ||
| Janus is leapfrogging the low-code, no-code solutions of today by developing a vertically integrated process improvement platform to revolutionize the way healthcare is worked.Only Janus offers process mining, modeling, and one-click automation in an accessible manner. Janus brings deep EHR and revenue cycle knowledge to ensure deep valuecreation rather than just another RPA platform. | $8M / Series A / Dec 14, 2021 | ||
| CaringWays is a private fundraising platform that works directly with healthcare providers and other organizations to help patients pay medical bills with greater ease, confidence, and security. The platform enables patients to raise needed funds for medical expenses while giving confidence to donors that their gifts will be used for theirintended purpose. | $2.5M / Series A / Nov 16, 2021 | ||
| Simplify ASC develops a customizable, easy-to-use, and indispensable clinical and operational software for the ambulatory surgery center market. The enterprise platform offers cloud-based, fully-integrated clinical and business applications combined with advanced reporting and analysis tools to help all levels of the ASC organization to makebetter, more timely decisions. | $9.5M / Series A / Jul 16, 2019 |
Co-Investors
IrishAngels
2 deals together
C2 Ventures
1 deal together
Dental Innovation Alliance
1 deal together
Ensemble Health Partners
1 deal together
Harpeth Capital
1 deal together
Incisive Ventures
1 deal together
Caduceus Capital Partners invest in great early-stage companies that recognize the seismic market shift driving unprecedented levels of innovation and digitization that enable new models of care delivery. It specializes in the fields of financial services, financial exchanges, and investment.
Caduceus Capital Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Dave Vreeland
Founder and Senior Managing Partner
|
|||
David Vreeland
Founder and Senior Managing Partner
|
|||
Scott Kolesar
Co-Founder and Managing Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Dave Vreeland invest in?
Dave Vreeland invests primarily in Health Care, Medical and Personal Health startups, most often at Series A and Venture - Series Unknown stage. Most of the 8 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Dave Vreeland?
Public channels for Dave Vreeland include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Dave Vreeland last invest?
The most recent investment recorded for Dave Vreeland closed in Jun 2025. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
